Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Innovation in Cancer Diagnosis
Connect with this vendor - Learn about this product

Cancer Self-Diagnostic Device

CUBEBIO’s cancer self-diagnostic device consists of an analyzer (the size of a toaster) and a sensor (the size of a USB flash drive). In simple terms, you put a urine sample on the sensor, insert it into the analyzer, and wait for the diagnostic results, which are shown on a screen mounted to the analyzer, in approximately 15 minutes.

We are able to detect cancers at an early and preventable stage that account for about 2/3 of cancer incidence and mortality rates worldwide. They include breast cancer, colorectal cancer, lung cancer, stomach cancer, liver cancer, pancreatic cancer, prostate cancer, and bladder cancer. When using the self-diagnostic device, it cannot only differentiate between existence and non-existence of these 8 cancer types with nearly 90% accuracy, but also identify and track the exact cancer type with 80-90% accuracy.

5 key features of the self-diagnostic device include:

  • Accuracy:

1) Differentiation between existence and non-existence of 8 cancer types with nearly 90% accuracy

2) Identification and tracking of 8 cancer types with 80-90% accuracy

  • Convenience:

1) Consumers are able to use without any assistance or consent from medical professionals

2) Portable and convenient to store, thereby allowing consumers to use regardless of location or time

  • Affordability:

1) Possible to self-diagnose cancers inexpensively

2) Treatment costs are 2 to 4 times lower when cancers are detected at the early stage

  • Safety:

1) Urine is the non-invasive specimen that gives neither side effects nor pain to consumers

2) Urine samples are easily collectible and hygienic

  • Accessibility:

1) Anyone can detect cancers at the early stage through frequent self-diagnosis

2) Cancer patients can monitor their cancer for progression or recurrence through frequent self-diagnosis